Performance-enhancing substances (PESs) have unfortunately become ubiquitous in numerous sports, often tarnishing the spirit of competition. Reported rates of PES use among athletes are variable and range from 5 to 31 %. More importantly, some of these substances pose a serious threat to the health and well-being of athletes. Common PESs include anabolic–androgenic steroids, human growth hormone, creatine, erythropoietin and blood doping, amphetamines and stimulants, and beta-hydroxy-beta-methylbutyrate. With recent advances in technology, gene doping is also becoming more conceivable. Sports medicine physicians are often unfamiliar with these substances and thus do not routinely broach the topic of PESs with their patients. However, to effect positive change in the sports community, physicians must educate themselves about the physiology, performance benefits, adverse effects, and testing methods. In turn, physicians can then educate athletes at all levels and prevent the use of potentially dangerous PESs.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Botre F, Pavan A. Enhancement drugs and the athlete. Neurol Clin. 2008;26:149–67.
De Rose EH. Doping in athletes: an update. Clin Sports Med. 2008;27:107–30.
WADA. World anti-doping code (online). 2015. https://wada-main-prod.s3.amazonaws.com/resources/files/wada-2015-world-anti-doping-code.pdf. Accessed 11 Aug 2014.
Mitchell G. Report to the Commissioner of Baseball of an independent investigation into the illegal use of steroids and other performance enhancing substances by players in Major League Baseball (online). http://files.mlb.com/mitchrpt.pdf. Accessed 11 Aug 2014.
Nilsson S. Androgenic anabolic steroid use among male adolescents in Falkenberg. Eur J Clin Pharmacol. 1995;48:9–11.
Korkia P, Stinson GV. Indication of prevalence, practice and effects of anabolic steroid use in Great Britain. Int J Sports Med. 1997;18:557–62.
Simon P, Striegel H, Aust F, et al. Doping in fitness sports: estimated number of unreported cases and individual probability of doping. Addiction. 2006;101:1640–4.
Striegel H, Simon P, Frisch S, et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2006;81:11–9.
Kanayama G, Gruber AJ, Pope HG Jr, et al. Over-the-counter drug use in gymnasiums: an unrecognized substance abuse problem? Psychother Psychosom. 2001;70:137–40.
Buckman JF, Yusko DA, White HR, et al. Risk profile of male college athletes who use performance-enhancing substances. J Stud Alcohol Drugs. 2009;70:919–23.
Dietz P, Ulrich R, Dalaker R, et al. Associations between physical and cognitive doping: a cross-sectional study in 2,997 triathletes. PLoS ONE. 2013;8:e78702.
Striegel H, Ulrich R, Simon P. Randomized response estimates for doping and illicit drug use in elite athletes. Drug Alcohol Depend. 2010;106:230–2.
Rexroat M. NCAA national study of substance use habits of college student-athletes (online). http://www.ncaa.org/sites/default/files/Substance%20Use%20Final%20Report_FINAL.pdf. Accessed 11 Aug 2014.
Sagoe D, Molde H, Andreassen CS, et al. The global epidemiology of anabolic-androgenic steroid use: a meta analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383–98.
Gregory AJ, Fitch RW. Sports medicine: performance-enhancing drugs. Pediatr Clin North Am. 2007;54:797–806.
Pereira HM, Padilha MC, Neto FR. Tetrahydrogestrinone analysis and designer steroids revisited. Bioanalysis. 2009;1:1475–89.
Teale P, Scarth J, Hudson S. Impact of the emergence of designer drugs upon sports doping testing. Bioanalysis. 2012;4:71–88.
Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543–53.
Evans N. Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004;32:534–42.
Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1–7.
Forbes GB, Porta CR, Herr BE, et al. Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA. 1992;267:397–9.
Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport. 1999;2:341–55.
Duntas LH, Popovic V. Hormones as doping in sports. Endocrine. 2013;43:303–13.
Broeder CE, Quindry J, Brittingham K, et al. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med. 2000;160:3093–104.
King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA. 1999;281:2020–8.
Wallace MB, Lim J, Cutler A, et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. 1999;31:1788–92.
Liddle DG, Connor DJ. Nutritional supplements and ergogenic AIDS. Prim Care. 2013;40:487–505.
Bahrke MS, Yesalis CE. Abuse of anabolic steroids and related substances in sport and exercise. Curr Opin Pharmacol. 2004;4:614–20.
Kanayama G, Kean J, Hudson JJ, et al. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013;130:208–14.
Geyer H, Schanzer W, Thevis M. Anabolic agents: recent strategies for their detection and protection from inadvertent doping. Br J Sports Med. 2014;48:820–6.
Brudnak MA. Creatine: are the benefits worth the risk? Toxicol Lett. 2004;150:123–30.
Eichner ER. Ergogenic aids: what athletes are using and why. Phys Sportsmed. 1997;25:70–83.
Greydanus DE, Patel DR. Sports doping in the adolescent athlete the hope, hype, and hyperbole. Pediatr Clin North Am. 2002;49:829–55.
Balsom PD, Soderlund K, Sjodin B, et al. Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation. Acta Physiol Scand. 1995;154:303–10.
Birch R, Noble D, Greenhaff PL. The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur J Appl Physiol Occup Physiol. 1994;69:268–76.
Dawson B, Cutler M, Moody A, et al. Effects of oral creatine loading on single and repeated maximal short sprints. Aust J Sci Med Sport. 1995;27:56–61.
Oliver JM, Joubert DP, Martin SE, et al. Oral creatine supplementation’s decrease of blood lactate during exhaustive, incremental cycling. Int J Sport Nutr Exerc Metab. 2013;23:252–8.
Earnest CP, Snell PG, Rodriguez R, et al. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand. 1995;153:207–9.
Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr. 1999;9:146–65.
Aaserud R, Gramyik P, Olsen SR, et al. Creatine supplementation delays onset of fatigue during repeated bouts of sprint running. Scand J Med Sci Sports. 1998;8:247–51.
Mujika I, Chatard JC, Lacoste L, et al. Creatine supplementation does not improve sprint performance in competitive swimmers. Med Sci Sports Exerc. 1996;28:1435–41.
Balsom PD, Ekbolm B, Soderlund K, et al. Creatine supplementation and dynamic high-intensity intermittent exercise. Scand J Med Sci Sports. 1993;3:143–9.
Balsom PD, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. 1994;18:268–80.
Claudino JG, Mezencio B, Amaral S, et al. Creatine monohydrate supplementation on lower-limb muscle power in Brazilian elite soccer players. J Int Soc Sports Nutr. 2014;11:e1–6.
Lemon PW. Dietary creatine supplementation and exercise performance: why inconsistent results? Can J Appl Physiol. 2002;27:663–81.
Dawson B, Vladich T, Blanksby BA. Effects of 4 weeks of creatine supplementation in junior swimmers on freestyle sprint and swim bench performance. J Strength Cond Res. 2002;16:485–90.
Bailes JE, Cantu RC, Day AL. The neurosurgeon in sport: awareness of the risks of heatstroke and dietary supplements. Neurosurgery. 2002;51:283–6.
Wen TC, Hae Tha M, Joo Ng H. Creatine supplementation and venous thrombotic events. Am J Med. 2014; 127;e7–e8.
Poortmans JR, Francaux M. Long term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc. 1999;31:1108–10.
NCAA Academic and Membership Affairs Staff. NCAA 2014-2014 division I manual (online). http://www.ncaapublications.com/productdownloads/D114.pdf. Accessed 11 Aug 2014.
Rickert VI, Pawlak-Morello C, Sheppard V, et al. Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr. 1992;31:723–6.
Liu H, Bravata DM, Olkin I, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008;148:747–58.
Baumann GP. Growth hormone doping in sports: a critical review of use and detection strategies. Endocr Rev. 2012;33:155–86.
Deyssig R, Frisch H, Blum WF, et al. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol. 1993;128:313–8.
Yarasheski KE, Campbell JA, Smith K, et al. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol. 1992;262:e261–7.
Rennie MJ. Claims for the anabolic effects of growth hormone: a case of the emperor’s new clothes? Br J Sports Med. 2003;37:100–5.
Saugy M, Robinson N, Saudan C, et al. Human growth hormone doping in sport. Br J Sports Med. 2006;40:i35–9.
Hanley J, Saarela O, Stephens D, et al. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing. Growth Horm IGF Res. 2014;24:205–15.
Veliz P, Boyd C, McCabe SE. Adolescent athletic participation and nonmedical Adderall use: an exploratory analysis of a performance-enhancing drug. J Stud Alcohol Drugs. 2013;74:714–9.
Ebert MH, Kammen DP, Murphy DL. Plasma levels of amphetamine and behavioral response. In: Gottschalk LA, Merlis S, editors. Pharmacokinetics of psychoactive drugs: blood levels and clinical response. New York: Wiley; 1976. p. 157–69.
Statland BE, Demas TJ. Serum caffeine half-lives: healthy subjects vs. patients having alcohol hepatic disease. Am J Clin Pathol. 1980;73:390–3.
Haller CA, Jacob P III, Benowitz N. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 2002;71:421–32.
Pentel P. Toxicity of over-the-counter stimulants. JAMA. 1984;252:1898–903.
Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc. 1980;12:65–9.
Gill ND, Shield A, Blazevich AJ, et al. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. Br J Clin Pharmacol. 2000;50:205–13.
Bell DG, Jacobs I. Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. Aviat Space Environ Med. 1999;70:325–9.
Bell DG, McLellan TM, Sabiston CM. Effect of ingesting caffeine and ephedrine on 10-km run performance. Med Sci Sports Exerc. 2002;34:344–9.
Santos VG, Santos VR, Felippe LJ, et al. Caffeine reduces reaction time and improves performance in simulated-contest of taekwondo. Nutrients. 2014;6:637–49.
Hodgson AB, Randell RK, Jeukendrup AE. The metabolic and performance effects of caffeine compared to coffee during endurance exercise. PLoS One. 2013;8:e1–10.
Stadheim HK, Kvamme B, Olsen R, et al. Caffeine increases performance in cross-country double-poling time trial exercise. Med Sci Sports Exerc. 2013;45:2175–83.
Lee CL, Cheng CF, Astorino TA, et al. Effects of carbohydrate combined with caffeine on repeated sprint cycling and agility performance in female athletes. J Int Soc Sports Nutr. 2014;11:e1–12.
Reyner LA, Horne JA. Sleep restriction and serving accuracy in performance tennis players and effects of caffeine. Physiol Behav. 2013;120:93–6.
Lattavo A, Kopperud A, Rogers PD. Creatine and other supplements. Pediatr Clin North Am. 2007;54:735–60.
Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta analysis. JAMA. 2003;289:1537–45.
McDuff DR, Baron D. Substance use in athletics: a sports psychiatry perspective. Clin Sports Med. 2005;24:885–97.
Greydanus DE, Patel DR. Sports doping in the adolescent: the Faustian conundrum of Hors de Combat. Pediatr Clin North Am. 2010;57:729–50.
Spriet LL, Graham TE. Caffeine and exercise performance (online). http://www.acsm.org/docs/current-comments/caffeineandexercise.pdf. Accessed 22 Nov 2014.
McLean BD, Gore CJ, Kemp J. Application of ‘live low-train high’ for enhancing normoxic exercise performance in team sport athletes. Sports Med. 2014;44:1275–87.
Morkeberg J. Blood manipulation: current challenges from an anti-doping perspective. Hematol Am Soc Hematol Educ Program. 2013;2013:627–31.
Citartan M, Gopinath SC, Chen Y, et al. Monitoring recombinant human erythropoietin abuse among athletes. Biosens Bioelectron. 2014;63:86–98.
Robertson RJ, Gilcher R, Metz KF, et al. Effect of induced erythrocythemia on hypoxia tolerance during physical exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982;53:490–5.
Berglund B, Hemmingson P. Effect of reinfusion of autologous blood exercise performance in cross-country skiers. Int J Sports Med. 1987;8:231–3.
Brien AJ, Simon TL. The effects of red blood cell infusion on 10-km race time. JAMA. 1987;257:2761–5.
Birkeland KI, Stray-Gundersen J, Hemmerbach P, et al. Effect of rhEPO administration on serum levels of s TfR and cycling performance. Med Sci Sports Exerc. 2000;32:1238–43.
Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med. 1991;229:125–30.
Leigh-Smith S. Blood boosting. Br J Sports Med. 2004;38:99–101.
Morkeberg J. Detection of autologous blood transfusions in athletes: a historical perspective. Transfus Med Rev. 2012;26:199–208.
Palisin T, Stacy JJ. Beta-hydroxy-beta-methylbutyrate and its use in athletics. Curr Sports Med Rep. 2005;4:220–3.
Pimentel GD, Rosa JC, Lira FS, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation stimulants skeletal muscle hypertrophy in rats via the mTOR pathway. Nutr Metab. 2011;8:e1–7.
Smith HJ, Mukerji P, Tisdale MJ. Attenuation of proteasome-induced proteolysis in skeletal muscle by beta-hydroxy-beta-methylbutyrate in cancer-induced muscle loss. Cancer Res. 2005;65:277–83.
Wilson JM, Kim J, Lee SR, et al. Acute and time effects of beta-hydroxy-beta-methylbutyrate (HMB) on indirect markers of skeletal muscle damage. Nutr Metab. 2009;6:e1–8.
Knitter AE, Panton I, Rathmacher JA, et al. Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol. 2000;89:1340–4.
Kraemer WJ, Hatfield DL, Volek JS, et al. Effects of amino acids supplement on physiological adaptations to resistance training. Med Sci Sports Exerc. 2009;41:1111–21.
Nissen SI, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol. 2003;94:651–9.
Hoffman JR, Copper J, Wendell M, et al. Effects of beta-hydroxy-beta-methylbutyrate on power performance and indices of muscle damage and stress during high-intensity training. J Strength Cond Res. 2004;18:747–52.
Kreider RB, Ferreira M, Greenwood M, et al. Effects of calcium b-HMB supplementation during training on markers of body composition, strength, and spring performance. J Exerc Physiology-online. 2000;3:48–59.
Wilson JM, Fitschen PJ, Campbell B, et al. International Society of Sports Nutrition position stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr. 2013;10:e1–14.
Gallagher PM, Carrithers JA, Godard MP, et al. Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass. Med Sci Sports Exerc. 2000;32:2109–15.
Nissen S, Sharp RL, Panton L, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J Nutr. 2000;130:1937–45.
Van der Gronde T, de Hon O, Haisma HJ, et al. Gene doping: an overview and current implications for athletes. Br J Sports Med. 2013;47:670–8.
Fischetto G, Bermon S. From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports? Sports Med. 2013;43:965–77.
Brill-Almon E, Stern B, Afik D, et al. Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Mol Ther. 2005;12:274–82.
Wang W, Li W, Ma N, et al. Non-viral gene delivery methods. Curr Pharm Biotechnol. 2013;14:46–60.
Sinn PL, Sauter SL, McCray PB Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors—design, biosafety, and production. Gene Ther. 2005;12:1089–98.
WADA. Therapeutic use exemptions (online). 2015. https://wada-main-prod.s3.amazonaws.com/resources/files/WADA-2015-ISTUE-Final-EN.pdf. Accessed 22 Nov 2014.
Vernec A. Therapeutic use exemptions: principles and practice (online). https://wada-main-prod.s3.amazonaws.com/resources/files/01-_vernec_alan_-_tue_symposium_paris_vernec_october_23_2014.pdf. Accessed 22 Nov 2014.
Little JC, Perry DR, Volpe SL. Effect of nutrition supplement education on nutrition supplement knowledge among high school students from a low-income community. J Community Health. 2002;27:433–50.
Whitaker L, Backhouse SH, Long J. Reporting doping in sport: national level athletes’ perceptions of their role in doping prevention. Scan J Med Sci Sports. 2014;24(6):e515–21.
Harcourt PR, Unglik H, Cook JL. Strategy to reduce illicit drug use is effective in elite Australian football. Br J Sports Med. 2012;46:943–5.
The authors would like to acknowledge Florence Lee, MD and Li-yuan Yu-Lee, PhD for their assistance with the preparation of figures for this manuscript. The authors have no potential conflicts of interest that are directly relevant to the content of this review. No sources of funding were used to assist in the preparation of this review.
Rights and permissions
About this article
Cite this article
Momaya, A., Fawal, M. & Estes, R. Performance-Enhancing Substances in Sports: A Review of the Literature. Sports Med 45, 517–531 (2015). https://doi.org/10.1007/s40279-015-0308-9
- Creatine Supplementation
- National Collegiate Athletic Association
- Major League Baseball
- Sprint Performance